A synthetic melanocortin agonist studied for skin pigmentation (tanning) and, secondarily, arousal. It is not approved, and research notes meaningful safety considerations.
Mechanism under study
Non-selectively activates melanocortin receptors, stimulating melanogenesis (via MC1R) and influencing appetite and arousal (via MC4R).
Research-reported dosing
Research-community references cite small amounts (~0.25–1 mg) during an initial period. It is unapproved; moles/pigmentation changes and nausea are noted research safety considerations.
Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.
A 500 mcg dose ≈ 10 units (50 mcg per unit).
Open this mix in the calculator →Source research-grade Melanotan II ↗Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
Melanotan II FAQ
What is Melanotan II?
A synthetic melanocortin agonist studied for skin pigmentation (tanning) and, secondarily, arousal. It is not approved, and research notes meaningful safety considerations.
What is the half-life of Melanotan II?
Reported around 30–60 minutes.
What is the research-reported dosing for Melanotan II?
Research-community references cite small amounts (~0.25–1 mg) during an initial period. It is unapproved; moles/pigmentation changes and nausea are noted research safety considerations.
How is Melanotan II reconstituted?
Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.
Is Melanotan II FDA-approved?
No — Melanotan II is not FDA-approved and is sold for laboratory research use only.
References
Guides featuring Melanotan II
Related peptides
PT-141
Melanocortin receptor agonist
A melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Studied for arousal via central nervous-system pathways rather than the vascular route.
GHK-Cu
Copper-binding tripeptide (Gly-His-Lys)
A naturally occurring copper-binding tripeptide whose plasma level declines with age. Extensively studied in skin biology for remodeling, and in topical cosmetic formulations.